Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves' disease

11Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Thyrotoxicosis-induced cardiomyopathy and consequent heart failure is one of the most grave complications of uncontrolled hyperthyroidism. In such patients, early recognition of thyrotoxicosis, and directed antithyroid therapy can lead to rapid normalization of left ventricular function. Herein, we present a case of a 29-year-old male with Graves' disease who developed heart failure with severe deterioration of left ventricular function and eventually, circulatory collapse. Height and weight of the patient were 1.8 m and 84 kg, respectively. The patient was placed on venoarterial extracorporeal membrane oxygenation for immediate circulatory support, with restoration of cardiac function after 6 days.

Cite

CITATION STYLE

APA

Allencherril, J., & Birnbaum, I. (2015). Heart failure in thyrotoxic cardiomopathy: Extracorporeal membrane oxygenation treatment for graves’ disease. Journal of Extra-Corporeal Technology, 47(4), 231–232. https://doi.org/10.1051/ject/201547231

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free